Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics

Publisher： Karger

E-ISSN： 1421-9832|227|4|305-310

ISSN： 1018-8665

Source： Dermatology, Vol.227, Iss.4, 2013-11, pp. : 305-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Etanercept in Psoriatic Patients Previously Treated with Infliximab

By  

Dermatology, Vol. 216, Iss. 4, 2008-01 ,pp. : 312-316

Karger

Access to resources Recommend Favorite

Impact of Adalimumab on Symptoms of Psoriatic Arthritis in Patients with Moderate to Severe Psoriasis: A Pooled Analysis of Randomized Clinical Trials

By  

Dermatology, Vol. 220, Iss. 1, 2009-11 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Association between Skin and Joint Involvement in Patients with Psoriatic Arthritis Treated with Adalimumab: Analysis of Data from a German Non-Interventional Study

By  

Dermatology, Vol. 230, Iss. 3, 2015-01 ,pp. : 213-221

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite

Leflunomide Improves Psoriasis in Patients with Psoriatic Arthritis: An In-Depth Analysis of Data from the TOPAS Study

By  

Dermatology, Vol. 212, Iss. 3, 2006-04 ,pp. : 238-249

Karger

Access to resources Recommend Favorite